On step two of the Alice/Mayo test, the Court found as follows:
VANDA PHARMACEUTICALS INC. and A VENTISUB LLC,. Plaintiffs, v. ... 1 Roxane concedes infringement of claim 3 of the' 198 Patent, provided that the claim is not proved invalid. ..... Laboratory tests are available to identify CYP2D6 PMs.
Aug 25, 2016 ... The suit is Vanda Pharmaceuticals Inc. et al. v. Roxane Laboratories Inc., case numbers 1:13-cv-01973 and 1:14-cv-00757, in the U.S. District ...
Vanda Pharmaceuticals Inc. v. Roxane Labs., Inc., Civil Action Nos. 12-1973- ... Pharmaceuticals and patent owner Aventisub sued ANDA applicant Roxane for.
Sep 6, 2016 ... In Vanda Pharmaceuticals Inc. v. Roxane Labs., Inc., Judge Sleet of the U.S. District Court for the District of Delaware upheld the patent ...
Jun 16, 2014 ... Plaintiff Vanda Pharmaceuticals Inc. (“Vanda”) for its Complaint against. Defendant Roxane Laboratories, Inc. (“Roxane”) alleges as follows: ... Corp. v. Roxane. Labs., Inc., 13-cv-1973 (D. Del.); Eisai Co. v. Roxane Labs., Inc.
Sep 26, 2016 ... In his opinion in a Hatch-Waxman litigation involving the anti-schizophrenia drug Iloperidone, Vanda Pharms., Inc. v. Roxane Labs., Inc., Civil ...
Nov 17, 2016 ... Before LOURIE, MAYER, and O'MALLEY, Circuit Judges. LOURIE, Circuit Judge. Roxane Laboratories, Inc. (“Roxane”) appeals from a.
Sep 14, 2016 ... In Vanda Pharmaceuticals Inc. v. Roxane Laboratories, Inc., 13-cv-01973 (D. Del. 2013), Vanda Pharmaceuticals Inc. and Aventisub LLC ...